Compare Marathon Petroleum Corp (MPC) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Marathon Petroleum Corp vs State Street SPDR S&P Biotech ETF — how do they compare? Marathon Petroleum Corp trades at $318.36 (market cap $92.05B), while State Street SPDR S&P Biotech ETF trades at $154.4. The key difference: Marathon Petroleum Corp pays a 1.24% dividend while State Street SPDR S&P Biotech ETF pays none, and Marathon Petroleum Corp is trading nearer its 52-week high, State Street SPDR S&P Biotech ETF nearer its low. Which is the better fit depends on your goals.
| MPC | XBI | |
|---|---|---|
Market Cap | $92.05B | — |
Sector | Energy | Broad Market / Factor |
52-Week High | $315.31 | $164.28 |
52-Week Low | $158.59 | $85.16 |
Enterprise Value | $124.23B | — |
Dividend Yield | 1.24% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Marathon Petroleum Corp
Marathon Petroleum is an independent refiner with 13 refineries in the midcontinent, West Coast, and Gulf Coast of the United States with total throughput capacity of 2.9 million barrels per day. Its Dickinson, ND, facility produces 184 million gallons a year of renewable diesel. Its Martinez, CA, facility will have the ability to produce 730 million gallons a year of renewable diesel once converted. The firm also owns and operates midstream assets primarily through its listed MLP, MPLX.
Read more on MPC →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
